Dr. Ryan Rush, MD
What this data tells you about Dr. Rush
Dr. Ryan Rush is an ophthalmology in Amarillo, TX, with 18 years in practice. Based on federal Medicare data, Dr. Rush performed 222,813 Medicare services across 8,909 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rush received a total of $3,958 from 7 pharmaceutical and/or device companies across 20 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are classified as financial or ownership interests (royalties, licensing fees, or investment interests). Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rush is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) | 194,460 | $29 | $60 |
| Retinal imaging (OCT scan) | 4,972 | $29 | $160 |
| Eye injection for retinal disease | 4,885 | $87 | $719 |
| Office visit, established patient (30-39 min) | 4,743 | $91 | $300 |
| Extended exam of the back part of the eye with optic nerve drawing | 3,254 | $12 | $75 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 2,876 | $101 | $315 |
| Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | 1,745 | $175 | $780 |
| Extended exam of the back part of the eye with retinal drawing | 1,587 | $19 | $75 |
| Aflibercept eye injection (Eylea) | 1,118 | $692 | $1,500 |
| Exam of blood vessels between the white part of eye and retina using a special camera after injection of a dye | 902 | $141 | $575 |
| Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye | 726 | $193 | $600 |
| Unclassified drugs | 692 | $1,778 | $7,717 |
| Exam of the internal drainage system of eye | 189 | $21 | $88 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 101 | $877 | $4,600 |
| Injection, bevacizumab, 10 mg | 97 | $54 | $115 |
| Steroid injection (triamcinolone) | 96 | $1 | $40 |
| New patient office visit (45-59 min) | 78 | $104 | $400 |
| Destruction of growth of retina using a laser | 67 | $395 | $1,625 |
| 2d ultrasound scan of eye tissue and structures | 59 | $35 | $235 |
| Comprehensive eye exam, established patient | 39 | $60 | $300 |
| Office visit, established patient, complex (40-54 min) | 35 | $122 | $400 |
| Removal of recurring cataract in lens capsule using a laser | 26 | $252 | $1,070 |
| Injection of drug or substance into membrane covering eyeball | 24 | $40 | $245 |
| Removal of eye fluid (vitreous) between lens and retina | 15 | $691 | $3,600 |
| Repair of detached retina with drainage and removal of eye fluid between lens and retina | 14 | $870 | $5,000 |
| New patient office visit, complex (60-74 min) | 13 | $139 | $500 |
Industry Payment Transparency
Open Payments through 2022 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2022)
Associated products mentioned in payments ›
Payments are distributed across multiple categories with no single dominant type.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2022 |
| Disciplinary History | — Not public | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Rush is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and mixed engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Rush experienced with eye injection (vabysmo/faricimab)?
Does Dr. Rush receive payments from pharmaceutical companies?
How do Dr. Rush's costs compare to other ophthalmologys in Amarillo?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology